Patient Square Capital acquires NanoString Technologies in a $220m deal, pending bankruptcy court approval.
Patient Square Capital, a healthcare-focused investment firm, has agreed to acquire NanoString Technologies for $220m in a deal that aims to provide continuity for customers and employees. NanoString Technologies, currently under Chapter 11 bankruptcy, is a leading provider of life science tools for research. The acquisition is subject to bankruptcy court approval and other standard closing conditions.
March 11, 2024
5 Articles